Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06343935
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-03
First Post:
2024-03-25
Brief Title:
A National Multicenter Real-world Study of Linperlisib in the Treatment of Lymphoma
Sponsor:
Shanghai YingLi Pharmaceutical Co Ltd
Organization:
Shanghai YingLi Pharmaceutical Co Ltd
Organization Data
Organization:
Shanghai YingLi Pharmaceutical Co Ltd
Class:
INDUSTRY
Study ID:
YY-20394-014
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai YingLi Pharmaceutical Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None